FEB 2021


Fullspeed towards clinical phase I


Our lead drug ALBUPLATIN is in the last exciting third of its preclinical development.


For our final boost we are now seeking a highly qualified



Key Qualifications


  • PhD in a relevant field (preferably toxicology, cancer biology, pharmacology, immunology)

  • At least 3 years of industrial experience in the preclinical studies sector, incl. regulatory submission-aimed preclinical development studies

  • Extensive expertise in project management of GLP / non-GLP animal experiments with rodents and non-rodents

  • Knowledge of GLP regulations, including writing SOPs and study reports

  • Being a team player, able to collaborate across multidisciplinary terms, and also have the ability to work independently

  • Ability to work in a start-up environment

  • Strong communication and interpersonal skills

  • Proficient English as well as German language skills




  • You are the interface between responsible authorities, ethics committees and scientists responsible to respond to health authority questions, coordinate and prepare all relevant documentation for pre-IND and IND submissions

  • Together with our scientists, you will design and manage in vivo studies in toxicology, pharmacology, pharmacokinetics and pharmacodynamics to meet regulatory requirements

  • Being involved in analysing and interpreting data and ensure compliances with GLP regulations in designing protocols




For this PART-TIME position we offer an annual gross salary of min. EUR 35.000,-, based on your qualifications and experience.

© P4 Therapeutics GmbH 2018-2020 • Waehringer Str. 42, AT-1090, Vienna

imprint/data protection